fr 139317 has been researched along with cytochalasin d in 1 studies
| Studies (fr 139317) | Trials (fr 139317) | Recent Studies (post-2010) (fr 139317) | Studies (cytochalasin d) | Trials (cytochalasin d) | Recent Studies (post-2010) (cytochalasin d) |
|---|---|---|---|---|---|
| 219 | 0 | 8 | 2871 | 0 | 440 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B; Morioka, T; Oite, T; Yao, J | 1 |
1 other study(ies) available for fr 139317 and cytochalasin d
| Article | Year |
|---|---|
Endothelin is a potent inhibitor of matrix metalloproteinase-2 secretion and activation in rat mesangial cells.
Topics: Animals; Antibodies, Monoclonal; Azepines; Cytochalasin D; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-2; Endothelin-3; Endothelins; Enzyme Activation; Gene Expression Regulation, Enzymologic; Glomerular Mesangium; Indoles; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Neutralization Tests; Nucleic Acid Synthesis Inhibitors; Rats; Rats, Wistar; Receptor, Endothelin A; Tissue Inhibitor of Metalloproteinase-2 | 2001 |